Literature DB >> 4033412

Liver involvement in sickle cell disease.

C S Johnson, M Omata, M J Tong, J F Simmons, J Weiner, D Tatter.   

Abstract

In an effort to clarify the features of hepatic dysfunction in sickle cell disease, we obtained serial tests of liver function in 100 consecutive patients with sickle cell anemia and in 30 consecutive patients with hemoglobinopathy SC during a five-year period. There were 32 patients with chronic abnormalities in tests of liver function. These abnormal tests were explained by a variety of lesions in 30 cases, and the liver disease remained unexplained in only 2 patients who declined liver biopsy. The diagnoses in these 30 patients included hepatitis, chronic passive congestion, common duct obstruction, alcoholic liver disease, pregnancy, collagen-vascular disease, and sarcoidosis. Evidence for hepatitis B infection was present in 19 of those with sickle cell anemia and in 6 of those with hemoglobinopathy SC. The bilirubin levels in sickle cell anemia appeared to have a trimodal distribution, with six patients exhibiting markedly elevated levels of indirect bilirubin suggesting a difference in bilirubin metabolism. There was no evidence of liver disease in 72 patients with sickle cell anemia, nor in 24 patients with hemoglobinopathy SC, as these patients exhibited only mild elevation of their serum indirect bilirubin levels owing to chronic hemolysis. Intrasinusoidal sickling and Kupffer cell erythrophagocytosis were nearly universal findings at liver biopsy, irrespective of the clinical disorder, and were not related to the degree of liver test abnormalities. Liver and biliary tract dysfunction in sickle cell disease have been attributed to anoxia secondary to sinusoidal obstruction by sickled erythrocytes and Kupffer cell erythrophagocytosis. However, some causes of liver disease in sickle cell patients can be explained by clinical disorders other than the hemoglobinopathy alone.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4033412     DOI: 10.1097/00005792-198509000-00007

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  19 in total

1.  Reversal of hepatic and renal failure from sickle cell intrahepatic cholestasis.

Authors:  Muhammad A Khan; John A Kerner
Journal:  Dig Dis Sci       Date:  2011-01-26       Impact factor: 3.199

Review 2.  Interventions for treating intrahepatic cholestasis in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Cristina Elena Martí-Amarista
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

3.  Biochemical indicator of sickle cell disease: preliminary report from India.

Authors:  S Pandey; A Sharma; S Dahia; V Shah; V Sharma; R M Mishra; Sw Pandey; R Saxena
Journal:  Indian J Clin Biochem       Date:  2011-09-25

4.  Liver stiffness increases acutely during sickle cell vaso-occlusive crisis.

Authors:  Christopher Koh; Tiffany Turner; Xiongce Zhao; Caterina P Minniti; Jordan J Feld; Jennifer Simpson; Mary Demino; Anna K Conrey; Mary J Jackson; Catherine Seamon; David E Kleiner; Gregory J Kato; Theo Heller
Journal:  Am J Hematol       Date:  2013-08-01       Impact factor: 10.047

Review 5.  Acute liver function decompensation in a patient with sickle cell disease managed with exchange transfusion and endoscopic retrograde cholangiography.

Authors:  Haris Papafragkakis; Mel A Ona; Kinesh Changela; Swayamprabha Sadanandan; Abraham Jelin; Sury Anand; Sushil Duddempudi
Journal:  Therap Adv Gastroenterol       Date:  2014-09       Impact factor: 4.409

6.  Pathological spectrum of liver diseases in sickle cell disease.

Authors:  M Omata; C S Johnson; M Tong; D Tatter
Journal:  Dig Dis Sci       Date:  1986-03       Impact factor: 3.199

Review 7.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

8.  Increased incidence of hepatitis B markers in children with sickle-cell anemia.

Authors:  P O Abiodun; O J Fatunde; K H Flach; T Buck
Journal:  Blut       Date:  1989-03

9.  Adverse effects of a clinically relevant dose of hydroxyurea used for the treatment of sickle cell disease on male fertility endpoints.

Authors:  Kea M Jones; Mohammad S Niaz; Cynthia M Brooks; Shannon I Roberson; Maria P Aguinaga; Edward R Hills; Valerie Montgomery Rice; Phillip Bourne; Donald Bruce; Anthony E Archibong
Journal:  Int J Environ Res Public Health       Date:  2009-03-16       Impact factor: 3.390

10.  An observational study of children with sickle cell disease in Kilifi, Kenya.

Authors:  Manish Sadarangani; Julie Makani; Albert N Komba; Tolu Ajala-Agbo; Charles R Newton; Kevin Marsh; Thomas N Williams
Journal:  Br J Haematol       Date:  2009-07-23       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.